Pharmaceuticals (352) | Underwriting Agreements (352)

Browse by Company

ACELRX PHARMACEUTICALS INC (1 contract)
Aclaris Therapeutics, Inc. (2)
Adamis Pharmaceuticals Corp (3)
ADIAL PHARMACEUTICALS, INC. (4)
AEON Biopharma, Inc. (1)
AGILE THERAPEUTICS INC (3)
ALDER BIOPHARMACEUTICALS INC (1)
Amylyx Pharmaceuticals, Inc. (2)
AN2 Therapeutics, Inc. (1)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (1)
ANI Pharma Inc (1)
APRICUS BIOSCIENCES, INC. (5)
Aquestive Therapeutics, Inc. (1)
ARTELO BIOSCIENCES, INC. (3)
ARVINAS, INC. (2)
ATAI Life Sciences B.V. (1)
Atea Pharmaceuticals, Inc. (1)
Athira Pharma, Inc. (2)
AVADEL PHARMACEUTICALS PLC (1)
AVENUE THERAPEUTICS, INC. (4)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (3)
Baudax Bio, Inc. (2)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Biofrontera Inc. (3)
Biohaven Ltd. (1)
BioPharmX Corp (1)
Blue Water Acquisition Corp. (7)
Bright Green Corp (1)
Bristol-Myers Squibb (2)
Canbiola, Inc. (2)
Cara Therapeutics, Inc. (1)
CASSAVA SCIENCES INC (1)
Catalent Inc (2)
Cerecor Inc. (5)
CHIASMA, INC (3)
CinCor Pharma, Inc. (2)
Cingulate Inc. (3)
Citius Pharmaceuticals, Inc. (3)
CNS Pharmaceuticals, Inc. (4)
Cocrystal Pharma, Inc. (3)
COGNITION THERAPEUTICS INC (3)
COLLEGIUM PHARMACEUTICAL, INC (1)
Context Therapeutics Inc. (1)
ContraVir Pharmaceuticals, Inc. (3)
CorMedix Inc. (1)
CymaBay Therapeutics, Inc. (3)
Cyteir Therapeutics, Inc. (1)
Dermata Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (2)
DURECT CORP (1)
Edgewise Therapeutics, Inc. (2)
Elanco Animal Health Inc (3)
Eleison Pharmaceuticals Inc (1)
Eloxx Pharmaceuticals, Inc. (3)
Eton Pharmaceuticals, Inc. (2)
Evofem Biosciences, Inc. (4)
Evoke Pharma Inc (1)
Evolus, Inc. (3)
EYEGATE PHARMACEUTICALS INC (4)
EYENOVIA, INC. (2)
EyePoint Pharmaceuticals, Inc. (4)
Fulcrum Therapeutics, Inc. (5)
GRAYBUG VISION, INC. (1)
Harmony Biosciences Holdings, Inc. (1)
HARROW HEALTH, INC. (5)
Haymaker Acquisition Corp. III (3)
Horizon Pharma plc (2)
Hoth Therapeutics, Inc. (4)
Ikena Oncology, Inc. (1)
IMARA Inc. (2)
INNOVATE BIOPHARMACEUTICALS, INC. (2)
Intra-Cellular Therapies, Inc. (3)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (2)
Johnson & Johnson (1)
Journey Medical Corp (2)
Kala Pharmaceuticals, Inc. (1)
Kaleido Biosciences, Inc. (3)
KEMPHARM, INC (2)
Landos Biopharma, Inc. (1)
Level Brands, Inc. (5)
Lexaria Bioscience Corp. (3)
Lilly (Eli) & Co. (6)
LIPELLA PHARMACEUTICALS INC (3)
Lipocine Inc. (1)
Liquidia Corp (1)
Liquidia Technologies Inc (2)
Longboard Pharmaceuticals, Inc. (2)
Lyra Therapeutics, Inc. (1)
MARINUS PHARMACEUTICALS INC (4)
Menlo Therapeutics Inc. (1)
Milestone Pharmaceuticals Inc. (2)
Mind Medicine (MindMed) Inc. (1)
MyoKardia Inc (2)
Neuralstem, Inc. (5)
NGM BIOPHARMACEUTICALS INC (2)
Novan, Inc. (2)
OCULAR THERAPEUTIX, INC (3)
Odonate Therapeutics, Inc. (2)
OMEROS CORP (3)
Onconova Therapeutics, Inc. (3)
OptiNose, Inc. (4)
ORAMED PHARMACEUTICALS INC. (1)
Osmotica Pharmaceuticals plc (3)
OTONOMY, INC. (2)
Panacea Acquisition Corp (2)
PaxMedica, Inc. (4)
Perrigo (1)
Pfizer (4)
Phathom Pharmaceuticals, Inc. (2)
PLIANT THERAPEUTICS, INC. (3)
PLx Pharma Inc. (1)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (1)
Provention Bio, Inc. (4)
Pulmatrix, Inc. (3)
Ra Pharmaceuticals, Inc. (1)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (1)
REATA PHARMACEUTICALS INC (2)
Recro Pharma, Inc. (3)
RELMADA THERAPEUTICS, INC. (2)
resTORbio, Inc. (3)
Revance Therapeutics, Inc. (3)
Roivant Sciences Ltd. (2)
Royalty Pharma plc (3)
Satsuma Pharmaceuticals, Inc. (1)
Scopus BioPharma Inc. (1)
scPharmaceuticals Inc. (2)
SCYNEXIS INC (3)
Sienna Biopharmaceuticals, Inc. (1)
Strongbridge Biopharma plc (1)
Tarsus Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (2)
Terns Pharmaceuticals, Inc. (3)
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
TFF Pharmaceuticals, Inc. (3)
The Medicines Company (1)
TherapeuticsMD, Inc. (3)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (1)
Tilray, Inc. (1)
TITAN PHARMACEUTICALS INC (5)
Trevi Therapeutics, Inc. (2)
Tricida, Inc. (1)
Trulieve Cannabis Corp. (1)
Vallon Pharmaceuticals, Inc. (2)
Ventyx Biosciences, Inc. (1)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (3)
Virpax Pharmaceuticals, Inc. (2)
Wave Life Sciences Ltd. (3)
XERIS PHARMACEUTICALS INC (2)
Zoetis (2)
ZOGENIX, INC. (1)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

Underwriting Agreement, dated as of March 1, 2023, among the Issuers, the Company, Citigroup Global Markets Europe AG, Citigroup Global Markets Inc., Goldman Sachs Bank Europe SE,... (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on March 3, 2023)
Underwriting Agreement, dated February 23, 2023, among Eli Lilly and Company and J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC and Morgan... (Lilly (Eli) & Co., Filed With SEC on February 24, 2023)
Underwriting Agreement, dated February 21, 2023, by and between the Company and Jefferies LLC (Verrica Pharmaceuticals Inc., Filed With SEC on February 21, 2023)
Underwriting Agreement by and among the Company, Evercore Group L.L.C. and Cantor Fitzgerald & Co. dated February 7, 2023 (Longboard Pharmaceuticals, Inc., Filed With SEC on February 8, 2023)
Underwriting Agreement, dated as of February 2, 2023, by and among Roivant Sciences Ltd., Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald... (Roivant Sciences Ltd., Filed With SEC on February 7, 2023)
Underwriting Agreement, dated February 2, 2023, between Avalo Therapeutics, Inc., SVB Securities LLC and RBC Capital Markets, LLC, as representatives of the several underwriters... (Cerecor Inc., Filed With SEC on February 3, 2023)
Underwriting Agreement, dated January 23, 2023 (CymaBay Therapeutics, Inc., Filed With SEC on January 25, 2023)
Underwriting Agreement, dated as of January 24, 2023, by and among Pliant Therapeutics, Inc. and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the... (PLIANT THERAPEUTICS, INC., Filed With SEC on January 25, 2023)
Underwriting Agreement, dated January 17, 2023, by and among Fulcrum Therapeutics, Inc., Goldman Sachs & Co. LLC, SVB Securities LLC and Piper Sandler & Co. as representatives of... (Fulcrum Therapeutics, Inc., Filed With SEC on January 18, 2023)
Form of Underwriting Agreement (Haymaker Acquisition Corp. III, Filed With SEC on January 3, 2023)
Underwriting Agreement, dated December 20, 2022, among Terns Pharmaceuticals, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters... (Terns Pharmaceuticals, Inc., Filed With SEC on December 23, 2022)
Notes Underwriting Agreement between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein, dated December 15, 2022 (HARROW HEALTH, INC., Filed With SEC on December 16, 2022)
Common Stock Underwriting Agreement between the Company and B. Riley Securities, Inc. dated December 13, 2022 (HARROW HEALTH, INC., Filed With SEC on December 16, 2022)
Underwriting Agreement relating to the Preferred Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the... (Recro Pharma, Inc., Filed With SEC on December 13, 2022)
Underwriting Agreement relating to the Common Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the... (Recro Pharma, Inc., Filed With SEC on December 13, 2022)
Form of Underwriting Agreement (LIPELLA PHARMACEUTICALS INC, Filed With SEC on December 13, 2022)
Form of Underwriting Agreement (LIPELLA PHARMACEUTICALS INC, Filed With SEC on December 8, 2022)
Underwriting Agreement, dated November 21, 2022, by and between OptiNose, Inc. and Piper Sandler & Co (OptiNose, Inc., Filed With SEC on November 23, 2022)
Underwriting Agreement, dated November 22, 2022, between scPharmaceuticals Inc., SVB Securities LLC and Cowen and Company, LLC, as representatives of the several underwriters... (scPharmaceuticals Inc., Filed With SEC on November 23, 2022)
Underwriting Agreement dated as of November 17, 2022 between the Company and JonesTrading Institutional Services LLC (TFF Pharmaceuticals, Inc., Filed With SEC on November 18, 2022)
Underwriting Agreement, dated as of November 8, 2022, between the Company and Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities... (Zoetis, Filed With SEC on November 16, 2022)
Underwriting Agreement by and between Cognition Therapeutics, Inc. and Cantor Fitzgerald & Co., dated November 10, 2022 (COGNITION THERAPEUTICS INC, Filed With SEC on November 14, 2022)
Underwriting Agreement, dated as of November 8, 2022, by and among Roivant Sciences Ltd., Cantor Fitzgerald & Co., and the Selling Shareholders named therein (Roivant Sciences Ltd., Filed With SEC on November 10, 2022)
Underwriting Agreement, dated November 7, 2022, by and among Marinus Pharmaceuticals, Inc., SVB Securities LLC, RBC Capital Markets, LLC and Cantor Fitzgerald & Co (MARINUS PHARMACEUTICALS INC, Filed With SEC on November 10, 2022)
First Amendment to Underwriting Agreement, dated November 4, 2022, by and between Rain Therapeutics Inc. and Guggenheim Securities, LLC (Rain Therapeutics Inc., Filed With SEC on November 7, 2022)
Underwriting Agreement, dated November 3, 2022, by and between Rain Therapeutics Inc. and Guggenheim Securities, LLC (Rain Therapeutics Inc., Filed With SEC on November 7, 2022)
Form of Underwriting Agreement (COGNITION THERAPEUTICS INC, Filed With SEC on November 7, 2022)
Form of Underwriting Agreement (LIPELLA PHARMACEUTICALS INC, Filed With SEC on October 24, 2022)
Form of Underwriting (Biohaven Ltd., Filed With SEC on October 18, 2022)
Underwriting Agreement, dated October 12, 2022 (DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on October 13, 2022)
Underwriting Agreement, dated October 6, 2022, by and between the Company and Aegis Capital Corp (AVENUE THERAPEUTICS, INC., Filed With SEC on October 12, 2022)
Form of Underwriting Agreement (AVENUE THERAPEUTICS, INC., Filed With SEC on October 5, 2022)
Form of Underwriting Agreement (Amylyx Pharmaceuticals, Inc., Filed With SEC on October 4, 2022)
Underwriting Agreement by and between Mind Medicine (MindMed) Inc. and RBC Capital Markets, LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein,... (Mind Medicine (MindMed) Inc., Filed With SEC on September 29, 2022)
Underwriting Agreement, dated September 22, 2022, by and among the Company and SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated and Oppenheimer & Co. Inc (Trevi Therapeutics, Inc., Filed With SEC on September 23, 2022)
Underwriting Agreement, dated as of September 13, 2022, among Edgewise Therapeutics, Inc. and the Representatives (Edgewise Therapeutics, Inc., Filed With SEC on September 14, 2022)
Underwriting Agreement, dated September 12, 2022, by and among the Company and the Underwriters (Revance Therapeutics, Inc., Filed With SEC on September 14, 2022)
Underwriting Agreement, dated August 25, 2022, by and among PaxMedica Inc., Craft Capital Management LLC and R.F. Lafferty & Co., Inc (PaxMedica, Inc., Filed With SEC on August 30, 2022)
Underwriting Agreement, dated August 15, 2022, by and among Fulcrum Therapeutics, Inc., Goldman Sachs & Co. LLC, and SVB Securities LLC as representatives of the several... (Fulcrum Therapeutics, Inc., Filed With SEC on August 17, 2022)
Underwriting Agreement dated as of August 12, 2022, by and between Palisade bio, Inc. and Ladenburg Thalmann & Co. Inc (Neuralstem, Inc., Filed With SEC on August 16, 2022)